Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Ark Med Soc ; 109(2): 44-5, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22984711

RESUMEN

Intestinal Failure is a complex and chronic condition that is challenging to patients, their families and their physicians. The intestinal rehabilitation team at Arkansas Children's Hospital adopts a multidisciplinary approach aimed at improving the outcomes of patients with Intestinal failure. The Intestinal Failure Improve Care Project will achieve these objectives through care coordination and monitoring, education and training of health care providers and families, pre-planned visits, and applications of evidence-based guidelines. The project will serve as an infrastructure for future clinical and translational research in the field.


Asunto(s)
Enterocolitis Necrotizante/terapia , Gastrosquisis/terapia , Hospitales Pediátricos/organización & administración , Atresia Intestinal/terapia , Pediatría/organización & administración , Arkansas , Niño , Humanos , Evaluación de Programas y Proyectos de Salud
3.
Clin Pediatr (Phila) ; 51(4): 337-44, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22013147

RESUMEN

OBJECTIVE: There are few established diagnostic tools to define non-IgE-mediated food hypersensitivity reactions. Cow milk protein allergy (CMPA) is a multisystem disorder affecting the gastrointestinal, skin, and lower and upper airway systems. This link is frequently missed because of subspecialty evaluation of the multisystem effects individually. The authors hypothesize that a more global evaluation based on a simple scored questionnaire will reveal this link. METHODS: Over an 18-month period, children younger than 2 years with non-IgE-mediated CMPA were identified. A symptom questionnaire was developed and scored and also applied to a control population. The prevalence of symptoms in each group was compared and a cumulative score was determined. Symptoms evaluated included gastrointestinal, aerodigestive, lower airway, and skin symptoms. A positive response was scored 1 and a negative response scored 0. RESULTS: Significant differences in prevalence rates between CMPA and control populations were noted, particularly in aerodigestive symptoms. There were marked differences in cumulative score between populations (P < .001). The authors identified a cut-off score at which there was close to 80% sensitivity and 90% specificity for distinguishing CMPA from a control population. CONCLUSION: A global evaluation of multiple systems can be an important diagnostic tool in determining CMPA in infants.


Asunto(s)
Técnicas de Apoyo para la Decisión , Hipersensibilidad a la Leche/diagnóstico , Estudios Transversales , Femenino , Humanos , Inmunoglobulina E/inmunología , Lactante , Masculino , Hipersensibilidad a la Leche/inmunología , Proyectos Piloto , Curva ROC , Estudios Retrospectivos , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios
4.
Arch Pediatr Adolesc Med ; 165(10): 884-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21784993

RESUMEN

OBJECTIVES: To determine if interventions during the pre-hemolytic uremic syndrome (HUS) diarrhea phase are associated with maintenance of urine output during HUS. DESIGN: Prospective observational cohort study. SETTINGS: Eleven pediatric hospitals in the United States and Scotland. PARTICIPANTS: Children younger than 18 years with diarrhea-associated HUS (hematocrit level <30% with smear evidence of intravascular erythrocyte destruction), thrombocytopenia (platelet count <150 × 10³/mm³), and impaired renal function (serum creatinine concentration > upper limit of reference range for age). INTERVENTIONS: Intravenous fluid was given within the first 4 days of the onset of diarrhea. OUTCOME MEASURE: Presence or absence of oligoanuria (urine output ≤ 0.5 mL/kg/h for >1 day). RESULTS: The overall oligoanuric rate of the 50 participants was 68%, but was 84% among those who received no intravenous fluids in the first 4 days of illness. The relative risk of oligoanuria when fluids were not given in this interval was 1.6 (95% confidence interval, 1.1-2.4; P = .02). Children with oligoanuric HUS were given less total intravenous fluid (r = -0.32; P = .02) and sodium (r = -0.27; P = .05) in the first 4 days of illness than those without oligoanuria. In multivariable analysis, the most significant covariate was volume infused, but volume and sodium strongly covaried. CONCLUSIONS: Intravenous volume expansion is an underused intervention that could decrease the frequency of oligoanuric renal failure in patients at risk of HUS.


Asunto(s)
Lesión Renal Aguda/etiología , Diarrea/terapia , Fluidoterapia , Síndrome Hemolítico-Urémico/terapia , Oliguria/etiología , Oliguria/prevención & control , Lesión Renal Aguda/prevención & control , Adolescente , Niño , Preescolar , Diarrea/complicaciones , Diarrea/microbiología , Femenino , Síndrome Hemolítico-Urémico/complicaciones , Síndrome Hemolítico-Urémico/orina , Humanos , Lactante , Modelos Logísticos , Masculino , Análisis Multivariante , Estudios Prospectivos , Resultado del Tratamiento
5.
J Pediatr ; 156(6): 941-947.e1, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20171649

RESUMEN

OBJECTIVE: This pilot study in parenteral nutrition-dependent infants with short bowel syndrome (SBS) evaluated the impact of feeding route and intestinal permeability on bloodstream infection (BSI), small bowel bacterial overgrowth (SBBO), and systemic immune responses, as well as fecal calprotectin as a biomarker for SBBO. STUDY DESIGN: Ten infants (ages 4.2-15.4 months) with SBS caused by necrotizing enterocolitis were evaluated. Nutritional assessment, breath hydrogen testing, intestinal permeability, fecal calprotectin, serum flagellin- and lipopolysaccharide-specific antibody titers, and proinflammatory cytokine concentrations (tumor necrosis factor-alpha [TNF-alpha], interleukin-1 beta, -6, and -8) were performed at baseline and at 60 and 120 days. Healthy, age-matched control subjects (n = 5) were recruited. RESULTS: BSI incidence was high (80%), and SBBO was common (50%). SBBO increased the odds for BSI (>7-fold; P = .009). Calprotectin levels were higher in children with SBS and SBBO versus those without SBBO and healthy control subjects (P < .05). Serum TNF-alpha, was elevated at baseline versus controls. Serum TNF-alpha and interleukin-1 beta, -6, and -8 levels diminished with increased enteral nutrition. Anti-flagellin and anti-lipopolysaccharide immunoglobulin G levels in children with SBS were lower versus control subjects and rose over time. CONCLUSION: In children with SBS, SBBO increases the risk for BSI, and systemic proinflammatory response decreases with increasing enteral feeding and weaning parenteral nutrition.


Asunto(s)
Intestino Delgado/microbiología , Sepsis/sangre , Síndrome del Intestino Corto/epidemiología , Nutrición Enteral , Enterocolitis Necrotizante/cirugía , Heces/química , Femenino , Flagelina/sangre , Humanos , Incidencia , Lactante , Interleucina-1beta/sangre , Interleucina-6/sangre , Interleucina-8/sangre , Complejo de Antígeno L1 de Leucocito/análisis , Masculino , Proyectos Piloto , Sepsis/epidemiología , Factor de Necrosis Tumoral alfa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...